2ϩ levels, leading to activation of myosin light chain kinase (MLCK) in smooth muscle and, as a result, MLC phosphorylation. This action is followed immediately by a decrease in MLC phosphatase (MLCP) activity and a resultant increase in MLC 20 phosphorylation, which induces further contraction, that is Ca 2ϩ sensitization. [1] [2] [3] [4] Multiple second messengers/signaling pathways including the RhoA/Rho-associated coiled-coil forming protein kinase (ROCK) [5] [6] [7] and protein kinase C (PKC) 8, 9) pathways, have reportedly been linked to Ca 2ϩ sensitization. An inhibitor protein specific for MLCP was isolated from pig aorta smooth muscle extracts and named CPI-17 for PKC-potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kDa.
levels, leading to activation of myosin light chain kinase (MLCK) in smooth muscle and, as a result, MLC phosphorylation. This action is followed immediately by a decrease in MLC phosphatase (MLCP) activity and a resultant increase in MLC 20 phosphorylation, which induces further contraction, that is Ca 2ϩ sensitization. [1] [2] [3] [4] Multiple second messengers/signaling pathways including the RhoA/Rho-associated coiled-coil forming protein kinase (ROCK) [5] [6] [7] and protein kinase C (PKC) 8, 9) pathways, have reportedly been linked to Ca 2ϩ sensitization. An inhibitor protein specific for MLCP was isolated from pig aorta smooth muscle extracts and named CPI-17 for PKC-potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kDa. 10) Phosphorylation of Thr 38 in CPI-17 converts it to a potent MLCP inhibitor with an IC 50 of ϳ5 nM. 10, 11) Phospho-CPI-17 enhances myosin phosphorylation and contraction of permeabilized arterial smooth muscle. 12) Airway hyperresponsiveness (AHR) associated with heightened airway resistance and inflammation is the asthmatic characteristic feature.
13) The importance of AHR in the cause of bronchial asthma was suggested by the correlation with the severity of the illness. 14) Our previous studies found the occurrence of both in vivo and in vitro hyperresponsiveness to ACh in rats that were actively sensitized and repeatedly challenged with aerosolized antigen. [15] [16] [17] In this animal model of AHR, no significant difference in the ACh-induced increase in cytosolic Ca 2ϩ concentration of the main bronchial smooth muscle was observed between the control and AHR rats. 18) Indeed, Ca 2ϩ sensitization in bronchial preparation of repeatedly antigen challenged rats was significantly enhanced as compared with that of control animals. 19) Moreover, an augmentation of CPI-17 expression and AChinduced phosphorylation of CPI-17 was induced in bronchial smooth muscle of repeatedly antigen challenged rats.
20)
ET-1 is a potent contracting substance for various smooth muscles including airways. In addition to the classical Ca 2ϩ -mediated contraction, 21) ET-1 also induced Ca 2ϩ sensitization of contraction. 22) ET-1 stimulation induces phosphorylation of CPI-17 in rabbit femoral artery 23) and vas deferens.
24)
However, it is not clear whether CPI-17 is involved in ET-1-induced Ca 2ϩ sensitization in airway smooth muscle of AHR rats. Endothelin-1 is an elevated level of endothelin-1 has been reported in the bronchoalveolar lavage fluids from asthmatic patients. 25) Thus, it might be important for asthma therapy to understand the detailed mechanism of endothelin-1-induced airway smooth muscle contraction. In the present study, phosphorylation of CPI-17 and MLC induced by ET-1 was determined in bronchial smooth muscle of rats. Furthermore, the levels of CPI-17 phosphorylation induced by ET-1 in bronchial smooth muscles of the AHR rats were compared with those of control animals.
MATERIALS AND METHODS

Animals
Male Wistar rats (6 weeks of age, specific pathogen-free, 170-190 g, Charles River Japan, Inc.) were used. All experiments were approved by the Animal Care Committee of Hoshi University (Tokyo, Japan).
Sensitization and Antigenic Challenge Rats were sensitized and repeatedly challenged with 2,4-dinitrophenylated Ascaris suum antigen (DNP-Asc) by the method described previously. 18, 19) The sensitized control group received the same immunization procedure except for inhaled saline aerosol instead of antigen challenge.
Western Blot Analyses Samples were prepared by the method described previously. 4, 20, 25) In brief, the bronchial tissue (containing the main and intrapulmonary bronchi) segments isolated from rats were equilibrated in oxygengated Krebs-Henseleit solution (37°C) for 60 min wih 15-min washout intervals. After the equilibration period, the tissue segments were stimulated by endothelin-1 for 15 min in the presence of atropine and indomethacin (both 10 Ϫ6 M). The reaction was stopped by quickly freezing with liquid nitrogen, and the tissue was then homogenized with T-PER TM Tissue Protein Extraction Reagent (Pierce) and centrifuged. Protein concentrations were determined using an Advanced Protein Assay Reagent (Cytoskeleton Inc.) with BSA as a standard. To quantify the phosphorylation of CPI-17 proteins, immunoblotting was performed as described previously. 25) Briefly, the samples (10 mg protein per lane) were subjected to 15% SDS-PAGE. Proteins were then electrophoretically transferred for 4 h onto PVDF membranes (Hybond-ECL, Amersham, Little Chalfont, U.K.) in cold transfer buffer (20% methanol containing Tris 25 mM and glycine 192 mM). After repeated washing with Tris buffer (Tris 20 mM, NaCl 500 mM, pH 7.5) containing 0.1% (v/v) Tween 20 (TTBS), the PVDF membranes were incubated with blocking buffer (3% gelatine in TTBS) for 1.5 h at room temperature. The PVDF membranes were then incubated with primary antibody, polyclonal goat anti-[Thr
38
-] phospho-CPI-17 (1 : 5000 dilution, Santa Cruz Biotechnology) in antibody buffer (1% gelatine in TTBS) for 12 h at room temperature. The PVDF membranes were then washed five times (each for 15 min) with TTBS. They were incubated with horseradish peroxidase (HRP)-conjugated anti-goat IgG (Amersham) for 1.5 h at room temperature, and then washed five times with TTBS. The blots were detected with an enhanced chemiluminescent method (ECL System; Amersham) and quantified by densitometry (Atto Densitograph Software ver. 4.0; Atto Co., Japan). To normalize the phosphorylated CPI-17 contents to an internal control protein, b-actin, immunoblotting was also performed on the same gel by using monoclonal mouse antib-actin N-terminal (Sigma, St. Louis, Missouri, U.S.A.) and goat anti-mouse IgG (Amersham). The ratios of corresponding phosphorylated CPI-17/b-actin in each lane were calculated as indices of phosphorylated CPI-17 protein level. In the ET-1-induced of MLC phosphorylation study, the bronchial preparation were stimulate by ET-1 10 Ϫ6 M for 15 min. Then the samples were homogenized with T-PER TM Tissue Protein Extraction Reagent (Pierce). After the samples (20 mg) were subjected to 15% SDS-polyacrylamide gel electrophoresis, western blot was performed. The membranes were incubated with the primary antibodies. As the primary antibodies were used goat anti-p-MLC (Thr18/Ser19, 1 : 1000 dilution; Santa Cruz Biotechnology, Inc.) or rabbit anti-myosin light chain (1 : 1000; Santa Cruz Biotechnology, Inc.). Then the membranes were incubated with horseradish peroxidase-conjugated donkey anti-goat immunoglobulin (Ig) G (1 : 5000 dilution; Santa Cruz Biotechnology, Inc.), detected by an ECL system. The ratio of corresponding p-MLC/MLC was calculated as an index of p-MLC.
Statistical Analyses Statistical significance of difference was determined by one-way analysis of variance (ANOVA) and Bonferroni/Dunn's test. A value of pϽ0.05 was considered significant.
RESULTS
ET-1-Induced Phosphorylation of CPI-17 in Bronchial Smooth Muscles from Repeatedly Antigen-Challenged
Rats We previously suggested that ET-1-induced contraction of bronchial smooth muscle was significantly enhanced in the repeatedly antigen-challenged group. 26) Currently, by using phospho [Thr38]-CPI-17 specific antibody, the phosphorylation of CPI-17 induced by ET-1 was determined in rat bronchial preparations. Because the expression of CPI-17 is enhanced by the repeatedly antigen-challenged, cellular phosphorylation level of CPI-17 was determined by comparison with the expression level of b-actin. The expression of bactin is unaffected by the repeatedly antigen-challenged. 20) As shown in Fig. 1 , incubation of bronchial preparation with ET-1 (10 Ϫ6 M, for 15 min) caused a distinct phosphorylation of CPI-17 in each group. In the bronchial smooth muscle of repeatedly antigen-challenged rats, the ET-1-induced phosphorylation of CPI-17 was significantly greater (ChallengedϩET-1: 632.7Ϯ107.1%) when compared with the seinsitized control animals (SensitizedϩET-1: 282.3Ϯ 29.1%, pϽ0.001).
ET-1-Induced Phosphorylation of MLC in Bronchial Smooth Muscles from Repeatedly Antigen-Challenged Rats As shown in Fig. 2 , the phosphorylation of MLC was also significantly increased by ET-1 (10 Ϫ6 M) stimulation in both groups. The ET-1 (10 Ϫ6 M)-induced phosphorylation was also more greatly augmented in the bronchial smooth muscle of repeatedly antigen-challenged rats (Sensitizedϩ ET-1: 572.0Ϯ86.5%, ChallengedϩET-1: 1072.2Ϯ213.1%, pϽ0.001).
DISCUSSION
Our previous study demonstrated that repeated challenge with aerosolized antigen to actively sensitized rats (the same methods as those used in the present study) causes distinct airway inflammation and remarkable AHR to inhaled acetyhlcholine (ACh) in vivo. 17) The isolated bronchial smooth muscles from these animals also exhibited a hyperresponsivenes to ACh and ET-1. 18, 26) A marked augmentation of ACh-induced Ca 2ϩ sensitization has been demonstrated in bronchial smooth muscle of this animal model of AHR. 18) Moreover, the expression of CPI-17 and ACh-induced phosphorylation of CPI-17 were significantly increased. 20) Here, both the CPI-17 and MLC phosphorylations induced by ET-1, a potent bronchoconstrictor that stimulates receptors other than muscarinic ones, were also augmented. There is report that phosphorylated CPI-17 enhances myosin phosphorylation and contraction of permeabilized smooth muscle. 12) Taken together, the phosphorylation of CPI-17 induced by ET-1 stimulation is involved in the bronchial smooth muscle hyperresponsiveness. In addition, it is interesting that unlike CPI-17 phosphorylation, the phosphorlation levels of MLC under stimulated condition are the same, even after antigen challenge. It seems that CPI-17 is important for MLC phosphorylation level under agonist stimulation.
We previously reported that ACh-induced Ca 2ϩ sensitization in b-escin-permeabilized bronchial smooth muscle was inhibited by a RhoA inhibitor, C3 exoenzyme, 19) or a ROCK inhibitor, Y-27632.
4) The RhoA/ROCK pathway seems to be considered as a major signaling pathway of the agonist-induced Ca 2ϩ sensitization in rat bronchial smooth muscle. Recently, the bronchial contraction and phosphorylations of CPI-17 and MLC induced by ACh and ET-1 were attenuated by pretreatment with Y-27632 treatment, suggesting that CPI-17 is phosphorylated via activation of ROCK in agonists-induced rat bronchial smooth muscle contraction (Sakai   et al., submitted data) . 27) Taken together, RhoA/ROCK/CPI-17 pathway may play an important role in agonist-induced Ca 2ϩ sensitization of among airway smooth muscle contraction.
In conclusion, the ET-1-induced CPI-17 phosphorylation was markedly increased in the bronchial smooth muscles of AHR rats as compared with that of the sensitized control group. Our data support that the augmented activation of CPI-17 observed in the hyperresponsive bronchial smooth muscle might be responsible for the enhanced agonists-induced contraction in AHR rats.
